• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

外泌体载药与靶向投递的当前策略

Current Strategies for Exosome Cargo Loading and Targeting Delivery.

机构信息

NMPA Key Laboratory for Research and Evaluation of Drug Metabolism, Guangdong Provincial Key Laboratory of New Drug Screening, School of Pharmaceutical Sciences, Southern Medical University, Guangzhou 510515, China.

出版信息

Cells. 2023 May 17;12(10):1416. doi: 10.3390/cells12101416.

DOI:10.3390/cells12101416
PMID:37408250
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10216928/
Abstract

Extracellular vesicles (EVs) such as ectosomes and exosomes have gained attention as promising natural carriers for drug delivery. Exosomes, which range from 30 to 100 nm in diameter, possess a lipid bilayer and are secreted by various cells. Due to their high biocompatibility, stability, and low immunogenicity, exosomes are favored as cargo carriers. The lipid bilayer membrane of exosomes also offers protection against cargo degradation, making them a desirable candidate for drug delivery. However, loading cargo into exosomes remains to be a challenge. Despite various strategies such as incubation, electroporation, sonication, extrusion, freeze-thaw cycling, and transfection that have been developed to facilitate cargo loading, inadequate efficiency still persists. This review offers an overview of current cargo delivery strategies using exosomes and summarizes recent approaches for loading small-molecule, nucleic acid, and protein drugs into exosomes. With insights from these studies, we provide ideas for more efficient and effective delivery of drug molecules by using exosomes.

摘要

细胞外囊泡(EVs),如外泌体和胞外体,作为药物递送的有前途的天然载体引起了关注。外泌体的直径在 30 至 100nm 之间,具有脂质双层,由各种细胞分泌。由于其高生物相容性、稳定性和低免疫原性,外泌体被视为理想的货物载体。外泌体的脂质双层膜还提供了对货物降解的保护,使其成为药物递送的理想候选物。然而,将货物装入外泌体仍然是一个挑战。尽管已经开发了各种策略,如孵育、电穿孔、超声处理、挤压、冻融循环和转染,以促进货物加载,但效率仍然不足。本综述概述了使用外泌体的当前货物递送策略,并总结了将小分子、核酸和蛋白质药物加载到外泌体中的最新方法。通过这些研究的见解,我们为使用外泌体更有效地递送药物分子提供了思路。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bc97/10216928/b20a9308c95e/cells-12-01416-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bc97/10216928/4463524adc41/cells-12-01416-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bc97/10216928/045a03bf71e4/cells-12-01416-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bc97/10216928/b20a9308c95e/cells-12-01416-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bc97/10216928/4463524adc41/cells-12-01416-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bc97/10216928/045a03bf71e4/cells-12-01416-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bc97/10216928/b20a9308c95e/cells-12-01416-g003.jpg

相似文献

1
Current Strategies for Exosome Cargo Loading and Targeting Delivery.外泌体载药与靶向投递的当前策略
Cells. 2023 May 17;12(10):1416. doi: 10.3390/cells12101416.
2
Drug loading techniques for exosome-based drug delivery systems.基于外泌体的药物传递系统的载药技术。
Pharmazie. 2021 Feb 25;76(2):61-67. doi: 10.1691/ph.2021.0128.
3
Recent advances in extracellular vesicles for therapeutic cargo delivery.细胞外囊泡在治疗性 cargo 递送上的最新进展。
Exp Mol Med. 2024 Apr;56(4):836-849. doi: 10.1038/s12276-024-01201-6. Epub 2024 Apr 1.
4
Challenges in the development and establishment of exosome-based drug delivery systems.基于外泌体的药物递送系统的开发和建立所面临的挑战。
J Control Release. 2021 Jan 10;329:894-906. doi: 10.1016/j.jconrel.2020.10.020. Epub 2020 Oct 12.
5
Extracellular Vesicles as Drug Transporters.细胞外囊泡作为药物转运体。
Int J Mol Sci. 2023 Jun 17;24(12):10267. doi: 10.3390/ijms241210267.
6
Extracellular Vesicles for Therapeutic Nucleic Acid Delivery: Loading Strategies and Challenges.细胞外囊泡用于治疗性核酸递送:装载策略和挑战。
Int J Mol Sci. 2023 Apr 14;24(8):7287. doi: 10.3390/ijms24087287.
7
Multiplexed strategies toward clinical translation of extracellular vesicles.细胞外囊泡临床转化的多重策略。
Theranostics. 2022 Sep 21;12(15):6740-6761. doi: 10.7150/thno.75899. eCollection 2022.
8
Encapsulation and assessment of therapeutic cargo in engineered exosomes: a systematic review.工程化外泌体中治疗性货物的包封和评估:系统评价。
J Nanobiotechnology. 2024 Jan 3;22(1):18. doi: 10.1186/s12951-023-02259-6.
9
Circulating Extracellular Vesicles As Biomarkers and Drug Delivery Vehicles in Cardiovascular Diseases.循环细胞外囊泡作为心血管疾病的生物标志物和药物递送载体
Biomolecules. 2021 Mar 5;11(3):388. doi: 10.3390/biom11030388.
10
Extracellular vesicles as novel drug delivery systems to target cancer and other diseases: Recent advancements and future perspectives.细胞外囊泡作为新型药物传递系统靶向癌症和其他疾病:最新进展和未来展望。
F1000Res. 2023 Mar 23;12:329. doi: 10.12688/f1000research.132186.1. eCollection 2023.

引用本文的文献

1
Engineered MSC-EVs loaded with BDNF-enhancing neuropeptides via a non-disruptive method enhance post-stroke neuroregeneration via intranasal delivery.通过一种非破坏性方法装载增强脑源性神经营养因子(BDNF)的神经肽的工程化间充质干细胞外泌体(MSC-EVs),经鼻内递送可增强中风后的神经再生。
J Nanobiotechnology. 2025 Aug 29;23(1):594. doi: 10.1186/s12951-025-03654-x.
2
Loading of Enzymatic Cargos into Extracellular Vesicles Derived from Lung Cancer Cells.将酶类货物装载到源自肺癌细胞的细胞外囊泡中。
Int J Nanomedicine. 2025 Aug 15;20:9931-9944. doi: 10.2147/IJN.S528193. eCollection 2025.
3
From bench to bedside: translating mesenchymal stem cell therapies through preclinical and clinical evidence.

本文引用的文献

1
Sequence determinant of small RNA production by DICER.Dicer产生小RNA的序列决定因素。
Nature. 2023 Mar;615(7951):323-330. doi: 10.1038/s41586-023-05722-4. Epub 2023 Feb 22.
2
Rejuvenation of tendon stem/progenitor cells for functional tendon regeneration through platelet-derived exosomes loaded with recombinant Yap1.通过负载重组Yap1的血小板衍生外泌体使肌腱干/祖细胞年轻化以实现功能性肌腱再生
Acta Biomater. 2023 Apr 15;161:80-99. doi: 10.1016/j.actbio.2023.02.018. Epub 2023 Feb 17.
3
Magnetic transferrin nanoparticles (MTNs) assay as a novel isolation approach for exosomal biomarkers in neurological diseases.
从实验台到病床边:通过临床前和临床证据转化间充质干细胞疗法。
Front Bioeng Biotechnol. 2025 Jul 30;13:1639439. doi: 10.3389/fbioe.2025.1639439. eCollection 2025.
4
Exosome Therapy: A Promising Avenue for Treating Intervertebral Disc Degeneration.外泌体疗法:治疗椎间盘退变的一条有前景的途径。
Tissue Eng Regen Med. 2025 Aug 7. doi: 10.1007/s13770-025-00746-5.
5
Role of miRNA‑214‑3p in cancer (Review).微小RNA-214-3p在癌症中的作用(综述)
Oncol Rep. 2025 Oct;54(4). doi: 10.3892/or.2025.8957. Epub 2025 Aug 1.
6
Mesenchymal Stem Cells: A Therapeutic Approach in Fertility Restoration in Premature Ovarian Insufficiency.间充质干细胞:一种用于恢复卵巢早衰生育能力的治疗方法。
Stem Cell Rev Rep. 2025 Oct;21(7):2089-2102. doi: 10.1007/s12015-025-10944-2. Epub 2025 Aug 1.
7
Application of Standardized Stem Cell-Derived Exosomes in Dermatological Wound Healing and Scar Management: A Retrospective Case-Series Study with Long-Term Outcome Assessment.标准化干细胞衍生外泌体在皮肤伤口愈合和瘢痕管理中的应用:一项具有长期结果评估的回顾性病例系列研究。
Pharmaceutics. 2025 Jul 14;17(7):910. doi: 10.3390/pharmaceutics17070910.
8
Circulating Extracellular Vesicles in Cardiovascular Disease.心血管疾病中的循环细胞外囊泡
Int J Mol Sci. 2025 Jul 16;26(14):6817. doi: 10.3390/ijms26146817.
9
Nanovesicular Drug Delivery Systems for Rare Ocular Diseases: Advances, Challenges, and Future Directions.用于罕见眼科疾病的纳米囊泡给药系统:进展、挑战与未来方向
AAPS PharmSciTech. 2025 Jul 23;26(7):197. doi: 10.1208/s12249-025-03159-8.
10
Recent developments of mesenchymal stem cell-derived extracellular vesicles in respiratory system diseases: A review.间充质干细胞衍生的细胞外囊泡在呼吸系统疾病中的研究进展:综述
Medicine (Baltimore). 2025 Jul 18;104(29):e43416. doi: 10.1097/MD.0000000000043416.
磁性转铁蛋白纳米颗粒(MTNs)检测作为一种用于分离神经疾病中外泌体生物标志物的新方法。
Biomater Res. 2023 Feb 16;27(1):12. doi: 10.1186/s40824-023-00353-2.
4
Exosomal circTUBGCP4 promotes vascular endothelial cell tipping and colorectal cancer metastasis by activating Akt signaling pathway.外泌体环状 RNA TUBGCP4 通过激活 Akt 信号通路促进血管内皮细胞突出和结直肠癌细胞转移。
J Exp Clin Cancer Res. 2023 Feb 15;42(1):46. doi: 10.1186/s13046-023-02619-y.
5
MiR146a-loaded engineered exosomes released from silk fibroin patch promote diabetic wound healing by targeting IRAK1.丝素蛋白贴片中释放的负载 miR146a 的工程化细胞外囊泡通过靶向 IRAK1 促进糖尿病伤口愈合。
Signal Transduct Target Ther. 2023 Feb 13;8(1):62. doi: 10.1038/s41392-022-01263-w.
6
Milk-derived exosomes carrying siRNA-KEAP1 promote diabetic wound healing by improving oxidative stress.牛奶来源的外泌体携带 siRNA-KEAP1 通过改善氧化应激促进糖尿病伤口愈合。
Drug Deliv Transl Res. 2023 Sep;13(9):2286-2296. doi: 10.1007/s13346-023-01306-x. Epub 2023 Feb 7.
7
Astrocyte-derived exosomal lncRNA 4933431K23Rik modulates microglial phenotype and improves post-traumatic recovery via SMAD7 regulation.星形细胞衍生的外泌体长非编码 RNA 4933431K23Rik 通过调节 SMAD7 调节小胶质细胞表型并改善创伤后恢复。
Mol Ther. 2023 May 3;31(5):1313-1331. doi: 10.1016/j.ymthe.2023.01.031. Epub 2023 Feb 3.
8
Tumor-intrinsic YTHDF1 drives immune evasion and resistance to immune checkpoint inhibitors via promoting MHC-I degradation.肿瘤内在的 YTHDF1 通过促进 MHC-I 降解来驱动免疫逃逸和对免疫检查点抑制剂的耐药性。
Nat Commun. 2023 Jan 17;14(1):265. doi: 10.1038/s41467-022-35710-7.
9
An Effective Peptide-Based Platform for Efficient Exosomal Loading and Cellular Delivery of a microRNA.一种有效的基于肽的平台,用于高效装载外泌体并将 microRNA 递送至细胞。
ACS Appl Mater Interfaces. 2023 Jan 25;15(3):3851-3866. doi: 10.1021/acsami.2c20728. Epub 2023 Jan 13.
10
Immune Exosomes Loading Self-Assembled Nanomicelles Traverse the Blood-Brain Barrier for Chemo-immunotherapy against Glioblastoma.负载自组装纳米胶束的免疫外泌体穿越血脑屏障用于胶质母细胞瘤的化学免疫治疗。
ACS Nano. 2023 Jan 10. doi: 10.1021/acsnano.2c10219.